Le Lézard
Classified in: Health, Science and technology, Business
Subject: SVY

Legacy and Fielded Medical Device Risks Pose Greatest Cybersecurity Challenge to Connected Device Ecosystem


NEW YORK, Aug. 15, 2017 /PRNewswire/ -- More than one-third (35.6 percent) of surveyed professionals in the Internet of Things-connected medical device ecosystem say their organizations have experienced a cybersecurity incident in the past year, according to a recent Deloitte poll. Identifying and mitigating the risks of fielded and legacy connected devices presents the industry's biggest cybersecurity challenge according to respondents (30.1 percent).

As used in this document, "Deloitte" means Deloitte LLP. Please see  www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. (PRNewsFoto/Deloitte)

"It's not surprising that managing cyber risks of existing IoT medical devices is the top concern facing manufacturers, providers, and regulators," said Russell Jones, Deloitte Risk and Financial Advisory partner, Deloitte & Touche LLP. "Legacy devices can have outdated operating systems and may be on hospital networks without proper security controls. Connected device cybersecurity can start in the early stages of new device development, and should extend throughout the product's entire lifecycle; but even this can lead to a more challenging procurement process. There is no magic bullet solution."

Additional cybersecurity challenges that connected medical devices presented to respondents included embedding vulnerability management into the design phase of medical devices (19.7 percent), monitoring and responding to cybersecurity incidents (19.5 percent), and lack of collaboration on cyber threat management throughout the connected medical device supply chain (17.9 percent).

Jones continued, "Collaboration between providers, manufacturers, and suppliers is key when it comes to bridging the gaps in medical device cybersecurity. This is a problem that requires the industry as a whole to come together and create a safe space where feedback and information can be shared freely."

Beyond cybersecurity risk management itself, there are post-incident risk management efforts to attend to as well. Few respondents (18.6 percent) say their organizations are "very prepared" to address litigation, internal investigations or regulatory matters related to medical device cybersecurity incidents in the next 12 months.

"As regulatory, litigation, and internal investigation activities start to focus on post-market cybersecurity management, leading organizations are taking a more forensic approach to discerning the timeline and size of cyber incidents so the impact to intellectual property, client data and other areas can be addressed more quickly," said Scott Read, Deloitte Risk and Financial Advisory principal, Deloitte Transactions and Business Analytics LLP. "Forensic analyses responding to regulator, litigant, or whistleblower concerns may even help predict the next moves of cyberattackers."

To protect against cyber threats in medical devices, Deloitte recommends a layered approach:

About the online poll
More than 370 professionals whose organizations operate in the medical device/IoT ecosystem responded to poll questions during the Deloitte Dbriefs webcast, "Medical devices and the Internet of Things: A three-layer defense against cyber threats," May 23, 2017. Respondent organizations include medical device or component manufacturers (i.e., implantables, diagnostic devices, capital equipment; 31 percent); health care IT organizations (i.e., mobile app/software developers; 22 percent); medical device users (i.e., health care providers, device monitoring; 36 percent); and regulators (10 percent). Answer rates differed by question.

About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including 80 percent of the Fortune 500. Our people work across more than 20 industry sectors to deliver measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to make their most challenging business decisions with confidence, and help lead the way toward a stronger economy and a healthy society. For more information, visit Deloitte's U.S. website at: http://www2.deloitte.com/us/en.html.

Contact

Lauren Hallman
Public Relations
Deloitte Services LP
+1 215 282 1213
[email protected]

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

SOURCE Deloitte


These press releases may also interest you

at 05:35
Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, has begun enrolling patients in the US for in a Phase 2b/3 clinical...

at 05:30
Blockbuster growth in weight-loss drugs was the main driver of a 13.5% increase in spending on prescription medications in the U.S. in 2023, according to ASHP's (American Society of Health-System Pharmacists) report, National Trends in Prescription...

at 05:26
Renowned orthopedic surgeon Dr. Dror Paley, in partnership with Dr. León Mora and the Cora Group Excellence Center for Orthopedic Reconstructive and Limb Lengthening Surgery, is...

at 05:15
The Industrial Technology Research Institute (ITRI) triumphed at the recent Edison Awardstm in Fort Myers, Florida, securing recognition for four exceptional technological breakthroughs: the Novel Dual-Targeted Therapy for Glaucoma, Key Functional...

at 05:00
The Beta-Glucan Market is estimated at USD 542 million in 2024 and is projected to reach USD 800 million by 2029, at a CAGR of 8.1% from 2024 to 2029 according to a report published by MarketsandMarketstm. The growth of the beta-glucan market is...

at 05:00
Geekplus, the global leader in mobile robot and smart logistics solutions, has deployed the first Shelf-to-Person PopPick project in the Nordics for one of the biggest online pharmacy wholesalers in the region, Med24.dk. System Teknik partnered on...



News published on and distributed by: